Estrella Immunopharma Inc. (ESLA) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Estrella Immunopharma Inc...

    NASDAQ: ESLA · Real-Time Price · USD
    1.31
    -0.01 (-0.76%)
    At close: Oct 03, 2025, 3:59 PM
    1.24
    -5.34%
    After-hours: Oct 03, 2025, 04:48 PM EDT

    Estrella Immunopharma Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2022 Jun 30, 2022
    PE Ratio
    		 -4.98 -5.3 -59.53 -34.71
    PEG Ratio
    		 -0.26 -0.23 1.44 -0.03
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 306.25 9.06 8.39 -56.26
    P/FCF Ratio
    		 -5.76 -2.41 -56.81 -40.57
    P/OCF Ratio
    		 -5.76 -2.41 -56.81 -40.57
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a n/a 0.07 n/a
    Quick Ratio
    		 0.55 24.65 0.05 5.20
    Current Ratio
    		 0.55 24.65 0.05 5.20
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -61.56 -1.71 -0.14 1.62
    Return on Assets
    		 -2.82 -1.64 -0.1 -0.34
    Return on Invested Capital
    		 -61.56 -1.71 -0.18 -0.03
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist